Research project
Framing the future: how AI medical device companies develop innovation capabilities and shape market narratives
- Principal investigator: Professor Krsto Pandza
- Co-investigators: Dr Youngbin Joo, Dr Serena Pugliese, Professor Hutan Ashrafian
- Postgraduate researcher: Haoyu Zhang
Description
Artificial Intelligence is revolutionising healthcare and medicine by enabling unprecedented advances in diagnostic accuracy, personalised treatment protocols, and predictive analytics that promise to transform patient outcomes.
As this transformative technology reshapes the medical landscape, there is a critical need to comprehensively analyse the competitive environment within this rapidly emerging field, where traditional healthcare companies, technology giants, and innovative startups are vying for market position and regulatory approval.
Understanding the distinct capabilities, technological approaches, and strategic positioning of companies is essential for the successful development of AI-enabled medical devices.
The success of these innovations also heavily depends on how effectively companies communicate their breakthrough technologies to diverse audiences, including clinicians, regulators, investors, and patients, making language and communication strategies pivotal to market adoption and public trust.
Furthermore, the complex regulatory landscape governing medical technology devices presents both opportunities and challenges for AI-driven healthcare solutions, as companies must navigate evolving regulatory guidelines, international standards, and ethical considerations while ensuring patient safety and efficacy in their AI-powered medical devices and diagnostic tools.
Publications and outputs
-
AI meets healthcare: why management matters more than technology, Research and Innovation Blog, February 2025